When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DBVT - DBV recovers some of yesterday's losses on peanut allergy trial; shares up 13%
DBV Technologies S.A.
Shares of DBV Technologies (DBVT +13.3%) have recouped some of their losses from yesterday after the company announced a new late-stage trial for its Viaskin peanut allergy patch. The trial will evaluate a modified patch that is 50% larger than a previous version. Kempen analyst Alex Cogut today downgraded DBV to neutral from buy with a $1.10 price target (~21% downside based on yesterday's close). In October, the FDA asked for more data from DBV on Viaskin.